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Present concepts of the maturation of a B-lymphocytic clone involve progres- 
sive changes in cellular morphology and mode of immunoglobulin (Ig) produc- 
tion. The ancestral small lymphocyte synthesizes Ig for insertion into its plasma 
membrane, while those of its descendants destined to produce humoral antibody 
show first a superimposed synthesis of Ig for export and finally a heavy export 
with little or no surface Ig apparent (1-4). In line with this apparent dichotom) 
of the surface and export pathways, turnover data make it unlikely that the 
material for export ever has a surface phase (3, 4). It is a central contention of 
the clonal selection theory that throughout this maturational process the varia- 
ble  (V) 1 regions of the  Ig heavy  and  light  chains,  responsible for  antibody 
activity and idiotypic antigenic specificity (5), remain unchanged. Experimental 
evidence supports this concept (6-8). 
Neoplasms appear to arise at various stages of B-cell maturation, developing 
with a  restricted range of morphologies and exhibiting modes of Ig synthesis 
broadly in line with their normal analogues (Fig. 1). The Ig products of a single 
tumor might be expected to bear a  uniform set of idiotypic determinants as a 
monoclonal hallmark.  This  is well established  for exported Ig,  in fact such 
products, appearing as serum monoclonal proteins, led to the first description of 
idiotypic specificity (9). Idiotypes on surface Ig have recently been demonstrated 
for those neoplasms exhibiting both surface and exported Ig. Here anti-idiotype 
sera raised against the exported Ig have reacted specifically with the homolo- 
gous tumor cell  surfaces  (10-15).  In one such case  mice immunized against 
idiotypic determinants on the exported Ig of a syngeneic myeloma were thereby 
afforded a measure of specific protection against tumor challenge (10), presum- 
ably due to cytotoxic reactions mediated via the surface idiotypic determinants. 
The nonexperting neoplasms to the left of Fig. 1 provide a situation where the 
tumor Ig appears in extracellular fluid in only minute quantities arising from 
turnover on the membrane. There is thus a problem in harvesting the Ig and 
obtaining antisera to its presumed idiotypic determinants. However, the thera- 
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FIG.  1.  The physiological transformation of a B-lymphoid clone and its possible neoplastic 
degenerations. Neoplasms can apparently arise at varioqs stages along the path of differen- 
tiation; the horizontal lines depict the ranges of cell morphologies and modes of Ig produc- 
tion commonly seen. Variations in the normal clone can occur due to the content of rough 
endoplasmic reticulum, indicating an export function, varying to some extent independ- 
ently of cell size. Additional complexities occur among the neoplasms without negating the 
overall validity of the scheme. 
peutic potential of such antisera appears much more attractive than in the case 
of exporting neoplasms, because there is little tumor Ig to form an extracellular 
barrier. 
Recently we were able to define idiotypic determinants on the surface IgM of 
nonexporting guinea pig leukemic lymphocytes (16). The antiserum had been 
raised by a procedure adaptable to routine use, entailing enzymatic removal of 
Fab from the surface Ig (17,  18), its recovery on immunosorbent particles, and 
immunization of animals with the immunosorbent-Fab complex (19). The solid 
phase of the immunosorbent was microcrystalline cellulose, chosen because its 
particles  were  largely  in  a  phagocytizable  size  range  (1-10  tzm).  Antibody 
coupled to the cellulose was specific for the constant regions of Fab and had been 
raised in the same species (sheep) as was to provide the anti-idiotype serum. In 
this way the definitive immunization utilized particles with no foreign configu- 
rations apart from the tumor Fab and the cellulose matrix. 
We now report the raising of anti-idiotype sera against surface Ig from two 
cases of a nonexporting human neoplasm, chronic lymphocytic leukemia (CLL). 
Materials and Methods 
Immunochemical Reagents.  IgO, Fab'T, IgM, and Fab~ were prepared from normal sera by 
conventional methods  (17). x- and k-light chains were prepared from urinary Bence Jones pro- 962  ANTI-IDIOTYPE  SERA 
teins. A sample of myeloma IgD was a gift from Dr. K. J. Dorrington. Antisera to these proteins 
were  raised  in  sheep  by  multiple  subcutaneous  injections  of emulsions  made  with  complete 
Freund's adjuvant  (Difco Laboratories,  Detroit,  Mich.).  For use  in direct immunofluorescence, 
fluorescein conjugates of antibody-containing IgG from the antisera were prepared, absorbed, and 
tested for specificity by methods previously described (17). 
Lymphocytes.  Venous blood was collected in heparinized bottles. Lymphocytes were separated 
and washed as previously described (17); it is important to note the incubation for 1 h at 37°C which 
is interpolated  into the washing procedures  so as to promote removal of plasma IgG from the 
cell surfaces.  The lymphocytes from Patients 1 and 2 are described in detail below. Lymphocytes 
for use  as controls were obtained  from five healthy  laboratory workers  and  from two further 
patients with CLL. 
Fab From Surface Ig.  Fab fragments from surface Ig molecules on leukemic lymphocytes were 
obtained in solution by subjecting the living cells at 10S/ml to surface proteolysis by papain  (0.5 
mg/ml, 30 min, 37  °) (17,  18). The cells were removed from the digest by centrifugation,  and the 
papain was inactivated by adding iodoacetamide to 5 mM. Amounts of Fab7 and Fab~ released 
were estimated by solid-phase radioimmunoassays (20). Each assay had been rendered specific for 
its individual class of Fab by appropriate absorptions of the antibodies. 
Fab was separated from the cell-surface digest by immunosorption onto particles of microcrys- 
talline cellulose (Merck A. G., Inc., Darmstadt,  W. Germany) to which sheep antibody to Fab'y 
had been coupled by the cyanogen bromide method (21). This immunosorbent is able to bind all 
classes of Fab due to its activity against their constituent light chains. After a preliminary blank 
absorption  with  cellulose-normal IgG,  the  immunosorbent-digest  suspension,  0.05%  vol/vol in 
terms of hydrated  particles,  was stirred for 24 h  at 4°C.  The particles were then separated  by 
centrifugation and washed four times in phosphate-buffered saline, pH 7.4. 
Preparation of Antibodies to Idiotypes (16).  Washed cellulose immunosorbent laden with Fab 
from tumor surface Ig was suspended at 1% vol/vol in phosphate-buffered saline and emulsified 
with an equal volume of complete Freund's adjuvant (Difco Laboratories). The emulsion was used 
to immunize two sheep for each patient,  using multiple subcutaneous  injections.  Primary  and 
secondary  injections were given 6 wk apart.  Each course of injections was accompanied by an 
intravenous (i.v.) injection of 30-ml sheep antiserum directed against the constant (C) regions on 
the predominant class of surface Ig; in the case of Patient 1 this was sheep antiserum to IgD, raised 
against a  myeloma protein of this class,  and in the case of Patient 2 it was sheep antiserum to 
human normal Fab~. The passive antiserum is designed to suppress the antibody response to the 
C regions on the tumor Fab and enhance the response to the V regions (19). 
The sheep were bled from the jugular vein 1, 2, and 3 wk after the booster injection. An IgG- 
containing fraction was precipitated from the serum with 1.6 M ammonium sulfate, and IgG2 (the 
electrophoretically slower of the two ovine IgG subclasses [22]) was then obtained by chromatogra- 
phy on diethylaminoethylcellulose (Whatman DE32) in 0.02 M sodium phosphate buffer, pH 7.0. 
These IgG2 fractions were immunoeleetrophoretically pure,  contained most of the anti-idiotypic 
activity, and were used as the source of anti-idiotype for all experiments reported in this paper. 
Absorptions were necessary for the IgG2 from anti-idiotype  (Patient  1) but not anti-idiotype 
(Patient 2).  Activity against  normal  human  cell surfaces,  detected by indirect immunofluores- 
cence, was removed by three absorptions at 50% vol/vol with red cells of blood group O and three 
absorptions with allogeneic leukemic lymphocytes at the same concentration (obtained by leuka- 
pheresis from  a  patient  with prolymphocytic leukemia,  and  kindly supplied by Dr.  A.  Okos). 
Activity against  Ig C  regions,  detected by Ouchterlony  precipitation,  was removed by passage 
through  a  column of Sepharose 4B  (Pharmacia  Fine Chemicals,  Piscataway,  N.  J.) coupled to 
globulins precipitated from human serum with 1.6 M ammonium sulfate. The antibody prepara- 
tions were finally adjusted to 4 mg IgG2/ml in phosphate-buffered  saline, pH 7.4. 
Characterization of Anti-idiotype  Sera  by Immunofluorescence and Inhibition  of Lymphocyte 
Migration.  Immunofluorescence was by the indirect method.  Washed cells at 107/ml in Eagle's 
medium containing 25% human  AB serum were mixed with an equal volume of IgG2 solution 
(anti-id~otype or control) and allowed to react for 30 min at 4°C. The cells were then washed three 
times  in  cold phosphate-buffered  saline  and  treated  with  fluorescein-conjugated  antiglobulin 
reagent for 30 min at 4°C. Finally, they were washed three times in saline containing 1% bovine 
serum albumin and 20 mM sodium azide, resuspended  in a  small volume of this medium,  and 
examined using a Leitz Orthoplan microscope equipped with a Ploem incident illuminator and 200 HOUGH,  EADY,  HAMBLIN,  STEVENSON,  AND  STEVENSON  963 
W  mercury  lamp.  The  use  of human  AB serum in the initial incubation reduced  background 
staining occurring with sheep normal IgG2, while the addition of azide to the final wash solutions 
prevented capping and pinocytosis (23). 
The ability of human leukemic lymphocytes to migrate from capillary tubes  (24) afforded the 
opportunity for assessing antibodies to their surface components by inhibition of migration (25, 
16). Duplicate samples of cells were allowed to migrate from glass capillary tubes (1 mm internal 
diameter) into medium (Eagle's, plus 1% nonessential amino acids, 10% fetal calf serum, and 100 
i.u./ml of both penicillin and streptomycin) containing varying concentrations of IgG2 from either 
anti-idiotypo or normal sheep serum. After migration had proceeded for 16 h at 37°C the relative 
areas covered were estimated by projecting the cell patterns onto paper, cutting out the shadowed 
areas,  and weighing. 
Patients.  Patient  1  (Pic)  is  a  75-yr-old man  who presented  in  August  1973 with  a  tender 
enlarged spleen.  There were slightly enlarged soft nodes in axillae and groins, Hb 16 g/100 ml, 
leukocytes 34,000/~1,  platelets 160,000/~1.  More than 80% of the leukocytes were small lympho- 
eytes which on electron microscopy revealed a large proportion of electron-transparent chromatin, 
numerous  mitochondria but  few other organelles,  and  occasional traces  of rough  endoplasmic 
reticulum. Fluorescence microscopy revealed surface IgD and IgM, at frequencies indicating that 
some cells were exhibiting both, with the light chain class restricted to ~  (Table I). During the 
ensuing 7 mo the patient's leukocyte count rose to 120,000/~1  and his spleen enlarged from 2 cm 
below the costal margin to 10 cm. At this stage 100 m| venous blood was collected for lymphocyte 
processing. Treatment with ehlorambucil (6 rag/day) reduced the leukocyte count to 10,000/~1  and 
splenomegaly to 3 cm. 9 mo after stopping treatment his spleen had enlarged to 10 cm and was 
causing  discomfort,  while  his  leukocyte  count  was  160,000/~1.  He  was  treated  with  further 
chlor~mbucil (8 mg/day) together with leukapheresis, reducing his leukocyte count to 6,000/~1 and 
his splenomegaly to 6 cm. 
Patient 2 (Eve) is a 66-yr-old woman who presented in July 1973 with an enlarged lymph node in 
the left submandibular region. Her Hb was 12.5 g/100 ml, leukocyte count 68,000/~1,  and platelets 
170,000/~1.  The blood film showed over 90% small lymphocytes, including many smear cells, and 
marrow examination was characteristic  of CLL.  The cells on electron microscopy were typical 
small  lymphocytes with  scanty  cytoplasm,  few  organelles,  and  no  visible rough  endoplasmic 
reticulum.  Fluorescent  microscopy  revealed  a  surface  Ig  characteristic  of B  cells:  there  was 
staining for IgM and more faintly for IgD with K-light chains. Again the frequencies of occurrence 
of the heavy chain classes suggested that some cells were exhibiting both (Table I). After 18 mo the 
leukocyte count was  130,000/~1  and  150 ml venous blood was taken for lymphocyte processing. 
21/2 yr after diagnosis the patient remained  asymptomatic  apart  from some concern about  the 
mass in her neck, but her Hb was now 0.9 g/100 ml and leukocyte count 240,000/~1. 
Results 
Isolation  of Surface Ig.  Freshly taken  peripheral  blood lymphocytes from 
both patients were washed and exposed to papain as described in Materials and 
Methods.  This procedure cleaves the surface IgM to release Fab~, which sur- 
vives the digestion antigenically intact (17). The amounts of Fab~ recovered are 
shown in Table II. That recovered from a control culture in the absence ofpapain 
is regarded as arising from IgM released by normal turnover on the membrane 
and by trauma incidental to dispersing the cells. The increment associated with 
exposure of the cells to papain probably arises from IgM cleaved in situ on the 
cell membrane  (18). 
The cell surface IgD is expected to have the same idiotypes as the IgM (12), so 
that Fab~ released from the cells can be used along with the Fab~ for the raising 
of anti-idiotype  sera.  Unfortunately  at  the  time  these  studies  on  material 
destined for use as immunogen were carried out we were unable to quantify the 
Fab8 in the digest.  A subsequent digestion of cells from Patient 1, using thiol- 
free papain at 0.5 mg/ml for 30 min at 37°C, yielded 70 ng Fab~t and 6 ng Fab8 
per 107 cells. The reason for the low yield of Fab~ is being investigated. 964  ANTI-IDIOTYPE  SERA 
TABLE  I 
Surface Immunoglobulin on Patients' Lymphocytes 
Percent of blood lymphocytes positive for 
T  /~  6  K 
Patient 1  5  29  78  4  56 
Patient 2  0  69  31  60  0 
Testing was by direct immunofluorescence  using conjugates of sheep IgG antibodies 
specific for the indicated Ig polypeptide chains. The small numbers of cells from 
Patient 1 staining for T and K are thought to reflect some residual contamination 
with plasma IgG. 
For Patient 1 the staining for 8 was stronger than for ~, while the reverse was the 
case for Patient 2. 
Cell surface IgG was observed irregularly in the two present cases of CLL and 
probably represents residual plasma IgG attached to Fcy receptors (26, 27). It 
would follow that the Faby found in the digest for Patient 2 is polyclonal and a 
perturbing factor in raising antibodies to the idiotypes of intrinsic tumor Ig. It 
was therefore removed by an immunosorbent specific for its FdT region; it can be 
seen from Table II that >90% of  the Faby was removed for an accompanying  loss 
of 26% of the Fab/~.  This procedure was not available when processing digest 
from Patient 1. 
Fab was now purified from the digests by immunosorption onto microcrystal- 
line cellulose and the cellulose-Fab complex used to raise anti-idiotype sera in 
sheep (see Materials and Methods). An assay of the digest from Patient 2 after 
immunosorption indicated that 66% of the Fab~ had been bound, so that the 
total dose of Fab~ given to each sheep was 7.5/zg, derived from approximately 6 
×  109 lymphocytes. For Patient 1 the doses of Fab/z were probably of a similar 
magnitude, being derived from 2.5  ×  109 lymphocytes for each animal immu- 
nized. 
Reactivity of Anti-idiotype Preparations with Leukemic Cells.  By indirect 
immunofluorescence anti-idiotype (Patient  1)  stained more than 80%  of the 
blood lymphocytes from this patient. Most of the cells showed a faint circumfer- 
ential ring with sparse superimposed bright spots.  Cells from Patient 2, from 
another case (Hor) of CLL, and from five normal subjects all failed to stain. 
Similarly anti-idiotype (Patient 2) stained more than 80% of  the blood lympho- 
cytes from Patient 2,  the predominant pattern being one of circumferential 
spots.  Again the control preparations were all negative: cells from Patient 1, 
from another case (Bee) of CLL, and from five normal subjects. 
The migrations of leukemic cells in the presence of antibody preparations, 
relative to their migrations in the presence of sheep normal IgG2, are set out in 
Table III. Despite some irregularities in the ratios it is clear that only in the 
presence of the homologous anti-idiotype is migration clearly inhibited, with 
this inhibition diluting out with the antibody. 
Confirmation of Molecular Target.  To prove that the specific reactivity of 
anti-idiotype (Patient 1) was associated with an antigenic target on the cell 
surface Ig, we took advantage of the ~capping' phenomenon in which two sets of 
antigenic determinants cap simultaneously if present on the same molecules but 
otherwise independently (23). HOUGH,  EADY,  HAMBLIN,  STEVENSON,  AND  STEVENSON 
TABLE  II 
Immunoglobulin  Obtained from Lymphocytic Surfaces 
965 
Ig (ng Fab/107 cells) detected in supernates after 
Culture in absence of papain  Culture in presence of papain 
Fab~  Fab~  Fab~  Fab~ 
Patient 1  9.2  ND  48  ND 
Patient 2  10.1  3.0  27  14 
Patient 2,  after removal  20  <1 
of Fab~ 
Estimations were by radioimmunoassay. ND, not done. 
The cells were cultured for 30 min at 37°C with or without papain at 0.5 mg/ml (see Materials and 
Methods). The solutions were then chilled and the cells removed by centrifuging. The supernate 
from the papain digest was  alkylated  so as to  inactivate the papain.  The supernate from the 
control culture was subjected to a 30-min digestion by papain, followed by alkylation, so as to yield 
similar molecular forms of Ig for comparison by the assay. 
The removal of Fab~ from the papain digest from Patient 2 was accomplished by adding,  to a 
concentration of 0.4% vol/vol, an immunosorbent consisting of anti-Fd~ coupled to microcrystal- 
line cellulose. After stirring for 24 h  at 4°C the immunosorbent was removed by centrifuging. 
In the first experiment lymphocytes from Patient 1 were exposed to polyspe- 
cific anti-Ig serum under capping conditions (cells at 2 ×  107/ml in 50% rabbit 
anti-human Fab'~ in Eagle's medium at 37°C for 30 min). This resulted in the 
surface Ig being completely capped or internalized, as judged by immediate 
subsequent staining of the chilled and washed cells by fluorescein-anti-IgD at 
4°C; there were only occasional cells with caps, the remainder being unstained. 
When, in place of anti-IgD, the cells were allowed to react with anti-idiotype 
(IgG2 at  1 mg/ml in  25%  human AB  serum at  4°C  for 30  min) followed by 
fluorescein-anti-sheep IgG as indicator, the staining pattern was the same as 
seen with fluorescein-anti-IgD. Thus, there was nothing to suggest the presence 
of non-Ig material on the cell surfaces reacting with the anti-idiotype prepara- 
tion. 
A second experiment demonstrated that the anti-idiotype preparation reacted 
with all the surface Ig molecules, in that capping by anti-idiotype involved all 
antigens reactive with antisera to Ig C regions. Capping had to be carried out by 
the sandwich method. Cells at 2 ×  107/ml were allowed first to react with anti- 
idiotype (IgG2 at 1 mg/ml in 25% human Ab serum) for 30 min at 4°C and were 
then washed and exposed to 50% rabbit anti-sheep IgG serum (not itself  reactive 
with the cells) for 30 min at 37°C. Subsequent staining of the chilled and washed 
cells by fluorescein-anti-IgD or anti-Fab'~, indicated that the surface Ig of most 
cells had been completely internalized, with only occasional cells retaining it in 
caps. The cells of Patient 2 did not survive the manipulations sufficiently well 
enough to permit these experiments to be applied to them. 
Discussion 
We draw two main conclusions from the experiments reported here. Firstly, 
immunoglobulin idiotypes  are  demonstrable  on  human  B-lymphocytic neo- 
plasms  which synthesize Ig  only for  insertion  into  the  surface membrane. 966  ANTI-IDIOTYPE  SERA 
TABLE  III 
Migration of Leukemic Lymphocytes in Presence of Anti-Idiotype 
Anti-idiotype  Migrating cells 
against cells  from 
from 
Relative migration at IgG concentrations (mg/ml) of 
4  2  1  0.5  0.25  0.125 
Patient 1  Patient 1  0.11  0.23  0.55  0.42 
Patient 2  1.2  1.2  0.73  1.3 
Patient Hor  1.5  1.1  1.2  1.5 
Patient 2  Patient 2  0.58  0.56  0.74  0.78 
Patient Bee  0.85  1.3  1.05 
Relative migration is defined as the ratio of the area covered by cells in the presence of IgG2 from 
anti-idiotype serum to the area covered by the same cells in the presence of IgG2 from normal 
sheep serum. The IgG2 from normal serum had been subjected to the same absorption procedures 
as had the antibody IgG~. 
The nonhomologous cells against which anti-idiotypes were tested were determined simply by 
availability at the time. 
Secondly, the raising of antisera to these idiotypes presents no serious technical 
problems. 
The evidence that our antisera are indeed directed against Ig idiotypic deter- 
minants resides in (a) the method of preparation whereby tumor Fab is pre- 
sented as immunogen, with any antibody response to the constant regions either 
suppressed or absorbed; (b) their specificity for the homologous tumor cells; (c) 
the coincident capping of surface Ig and the targets of the antisera. 
Although the immunization schedule is still at an early stage of refinement, 
success was achieved with the first two human cases to which it was applied 
aider its feasibility was demonstrated in an animal leukemia (16). So practical 
difficulties do not appear to loom large, and we are hopeful that considerable 
improvement in the quality of  the antisera wilt be possible.  We are reinvestigat- 
ing the immunization schedule with regard to the nature of the solid phase, the 
route  of immunization,  and  the  value  of passive  antiserum  in  specifically 
suppressing the response to the C regions. 
An extension of  our approach to the obtaining of anti-idiotype sera against the 
surface Ig of B lymphomas with no obvious leukemic phase should be dependent 
only upon obtaining sufficient cells  in  a  dispersed form: from effusions, by 
dispersing solid tumor, or by the vigorous harvesting of small leukemic over- 
spills from peripheral blood. 
We have preferred to isolate surface Ig by the action of papain on intact cells, 
rather than by harvesting culture supernates or disrupting plasma membranes 
by agents such as detergent. Papain appears to give a high yield of Fab~ from 
surface IgM, although the yield of Fab8 from surface IgD has still to be defined. 
The other methods mentioned should yield whole Ig molecules, with a greater 
proportion of determinants irrelevant for our purposes. Ig shed spontaneously 
from the cell surface might even have additional membrane constituents at- 
tached to it  (28). The alternative methods also have no obvious quantitative 
advantages. The potential yield of Ig upon simple harvesting of culture fluid is 
apt to be less than implied by the 30-min figures in Table II, as these undoubt- HOUGH~ EADY, HAMBLIN~ STEVENSON,  AND  STEVENSON  967 
edly include a contribution from trauma on dispersing the cells. Disrupting the 
cells by detergent or other means will yield a  lot of intracellular material to 
render immunosorption more difficult. Nor is it likely to give access to much 
more cellular Ig, as most of this is on the surface in nonexporting cells (29). 
The anti-idiotype sera are of potential diagnostic and prognostic value. Hav- 
ing been raised against cells taken before the tumor is suppressed by treatment 
they could be useful in identifying neoplastic cells in blood or marrow, thereby 
predicting clinical relapse. Such an antiserum has already helped to identify 
sublines of the guinea pig L2C lymphocytic leukemia (30). 
The therapeutic potential of the antisera is a  more difficult question. Mice 
immunized by  a  conventional schedule against  the  idiotypes on  a  purified 
myeloma protein exhibited some resistance to inoculations of the corresponding 
plasmacytoma (10). However, in the only relevant study available to date there 
is no evidence that surface Ig idiotypes can act as a 'tumor-specific transplanta- 
tion  antigen' in the usual  sense; a  subline of the guinea pig L2C  leukemia 
lacking Ia antigen but retaining surface IgM (and idiotypes) afforded no protec- 
tion against itself  or other idiotype-bearing  sublines when whole cells were used 
as immunogen in syngeneic animals (30). Clearly the situation we describe, in 
which xenogeneic anti-idiotype serum is made available in almost arbitrarily 
large quantities, is different from the preceding two. We are investigating the 
therapeutic possibilities in the L2C leukemia and in certain human cases. It is 
probably important to note that the best known pathways whereby antibodies 
kill cells,  complement-mediated and K-cell-mediated cytotoxicities, do not al- 
ways work across species barriers. Thus, it is desirable to identify the class of Ig 
in which the predominant anti-idiotype activity resides and then to ascertain 
whether this class is capable of  collaborating with the complement and K cells of 
the species to be treated.  Other experimentally defined effects of antibodies 
against surface antigens on lymphoid or neoplastic clones might also prove 
therapeutically relevant: invoking of suppression by T cells (31), stimulation 
(32), and synergism with cytotoxic drugs (33). 
Summary 
The idiotypic determinants of surface immunoglobulins on B-cell lymphomas 
and  lymphocytic leukemias  represent  tumor-specific antigens,  individually 
unique for each tumor. As such they have both diagnostic and therapeutic poten- 
tial, particularly for those neoplasms with no serum monoclonal immunoglobu- 
lin arising from synthesis of the protein for export. We describe the raising in 
animals of anti-idiotype sera directed against two examples of a nonexporting 
neoplasm, human chronic lymphocytic  leukemia. The procedure involves expos- 
ing the  cells to  papain  so  as  to  remove the  Fab  fragments (containing the 
idiotypic determinants) from the surface immunoglobulin, recovering the Fab 
on cellulose immunosorbent particles, and immunizing animals with the immu- 
nosorbent-Fab complex. 
We are grateful  to the staff  of Allington Farm, Porton Down, Wiltshire for providing  facilities  for 
immunizing sheep. 
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